Search

Your search keyword '"Wetzke, Martin"' showing total 294 results

Search Constraints

Start Over You searched for: "Wetzke, Martin" Remove constraint "Wetzke, Martin"
294 results on '"Wetzke, Martin"'

Search Results

51. Interventional Bronchus Occlusion Using Amplatzer Devices – A Promising Treatment Option for Children with Persistent Air Leak

52. Persistent Tachypnea of Infancy. Usual and Aberrant

54. Biomarkers of DNA Damage Response Enable Flow Cytometry-Based Diagnostic to Identify Inborn DNA Repair Defects in Primary Immunodeficiencies

55. Specifying pediatric pulmonary hemorrhage: Suggestion of a diagnostic algorithm as guide to disease subcategories

57. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment

58. Non-Appearance of the RSV Season 2020/21 During the COVID-19 Pandemic

59. Interobserver agreement in interpretation of chest radiographs for pediatric community acquired pneumonia: Findings of the pedCAPNETZ‐cohort

60. Interobserver agreement in interpretation of chest radiographs for pediatric community acquired pneumonia: Findings of the pedCAPNETZ-cohort

62. Gene Correction of Human Induced Pluripotent Stem Cells Repairs the Cellular Phenotype in Pulmonary Alveolar Proteinosis

63. Acute exacerbations in children's interstitial lung disease.

64. Healthcare resource utilisation and medical costs for children with interstitial lung diseases (chILD) in Europe.

65. SARS-CoV-2 Antibodies in Children: A One-Year Seroprevalence Study From June 2020 to May 2021 in Germany

67. Transient interventional bronchus occlusion as a new treatment approach for persistent bronchopleural fistula complicating necrotizing pneumonia in four children

68. Assessment of fibrosis in lung biopsies from the European childhood interstitial lung disease (chILD) registry

69. Persistent tachypnea of infancy: Follow up at school age

70. Strategic anti-SARS-CoV-2 serology testing in a low prevalence pandemic: The COVID-19 Contact (CoCo) Study in health care professionals

71. An apple a day won't keep the doctor away: presentation, treatment, and outcome in pediatric apple aspirations

72. Superimposed mosaicism in cutaneous sarcoidosis: A hypothesis.

74. Novel Genetic Risk Markers for Ulcerative Colitis in the IL2/IL21 Region Are in Epistasis With IL23R and Suggest a Common Genetic Background for Ulcerative Colitis and Celiac Disease

76. rs224136 on Chromosome 10q21.1 and Variants in PHOX2B, NCF4, and FAM92B Are Not Major Genetic Risk Factors for Susceptibility to Crohnʼs Disease in the German Population

77. Additional file 1 of Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial

78. The ATG16L1 Gene Variants rs2241879 and rs2241880 (T300A) Are Strongly Associated With Susceptibility to Crohnʼs Disease in the German Population

80. MOESM1 of PedCAPNETZ – prospective observational study on community acquired pneumonia in children and adolescents

81. Pulmonary interstitial Glycogenosis – a systematic analysis of new cases

82. One-year outcomes in a multicentre cohort study of incident rare diffuse parenchymal lung disease in children (ChILD)

84. PedCAPNETZ – prospective observational study on community acquired pneumonia in children and adolescents

85. Pregnancy Related Health Care Needs in Refugees : A Current Three Center Experience in Europe

87. Pulmonary interstitial Glycogenosis – a systematic analysis of new cases

89. Tuberculosis Specific Interferon-Gamma Production in a Current Refugee Cohort in Western Europe

91. Improved protocol for simultaneous analysis of leukocyte subsets and epithelial cells from murine and human lung

92. BASICS Bildgebende Verfahren

93. International management platform for children’s interstitial lung disease (chILD-EU)

94. Norovirus outbreaks in german refugee camps in 2015

96. Analysis of children’s diffuse parenchymal lung disease from the European Management Platform for Childhood Interstitial Lung Diseases: Frequency of disease categories and treatments used

98. Labyrinthopeptin A1 and A2 efficiently inhibit cell entry of hRSV isolates

99. One-year outcomes in a multicentre cohort study of incident rare diffuse parenchymal lung disease in children (ChILD).

100. The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease

Catalog

Books, media, physical & digital resources